Lyudmil Todorov, MD
Anesthesiology · Pawtucket, RINPI 1477661734
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Boston Scientific at 32.2% of the total. Reporting peaked in 2021 at $124 and has fallen 77.6% since, to $28 in 2025.
Across 27 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$154
- Nevro Corp.$52
- Abbott$48
- Pfizer$45
- Vertos Medical, Inc.$33
- MML US, Inc.$30
- plus $117 from 6 others
What the payments were for
- Food & beverage$479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $154 |
| Nevro Corp. | 2 | $52 |
| Abbott | 2 | $48 |
| Pfizer | 3 | $45 |
| Vertos Medical, Inc. | 2 | $33 |
| MML US, Inc. | 3 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Medtronic | 1 | $24 |
| Valinor Pharma, LLC | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $12 |
How this compares
$479 in reported general payments places this provider in the 85th percentile of 122 anesthesiology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 69 | $1,116 |
| Tizanidine Hcl | 33 | $419 |
| Lidocaine | 17 | $405 |
| Diclofenac Sodium | 19 | $389 |
| Duloxetine Hcl | 22 | $353 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $343 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $210 |
| Tramadol Hcl | 14 | $110 |
| Cyclobenzaprine Hcl | 13 | $50 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Pawtucket
- Edgardo RodriguezPawtucket$327
- Jose DeleonPawtucket$199
- Susan WalkerPawtucket$153
- Ataollah Hassani AfsharPawtucket$104
- Harish LecamwasamProvidence$436K
- William YelleProvidence$5K
- Andrew MaslowProvidence$5K
- Keith ScarfoProvidence$4K
- David LareauWarwick$1K
- Derek KellerProvidence$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.